The Interleukin-1 (IL-1) Market — growing at a 9.5% CAGR from USD 1.2 billion (2024) to USD 2.5 billion (2033) — is entering a phase of significant pipeline expansion, competitive entry from novel therapeutic modalities, and geographic diversification. Understanding the competitive and innovation landscape is essential for stakeholders navigating a market that is simultaneously an...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
